Pilar Giraldo – Medical field – Lifetime achievement Award

Posted on by ScienceFatherLeave a Comment on Pilar Giraldo – Medical field – Lifetime achievement Award

Pilar Giraldo – Medical field – Lifetime achievement Award

Dr. Pilar Giraldo distinguished academic and researcher in the field Identification of patient-reported outcome measures and patient-reported experience measures in Gaucher disease in Spain. Dr. Pilar Giraldo Castellano appears highly suitable for the Research for Lifetime Achievement Award based on her extensive contributions and accomplishments in the field of hematology, particularly focusing on rare diseases.

🌐 Professional Profile

Educations📚📚📚

  • PhD in Medicine and accredited as a Full Professor by ANECA.
  • Master’s in Research Methodology and Molecular Oncology.
  • Coordinator of Doctorate studies at University San Jorge.

  • Research and Publications:

    • Head of research group Unit 752 of the Center for Biomedical Research Network on Rare Diseases (CIBERER).
    • Published over 140 articles in peer-reviewed journals, more than 20 book chapters, and 5 monographs.
    • Holds 5 patents related to her field.

  • Leadership in Research Projects:

    • Principal Investigator in numerous significant projects, such as the National Plan project TED2021-131518B-C32.
    • Directed more than 20 doctoral theses.
    • Led various research initiatives focusing on lysosomal diseases and other hematological conditions.

  • International Recognition and Collaboration:

    • Organized national and international congresses, including the 12th EWGGD Congress in 2016.
    • Part of the Expert Committee of the IWGGD and the Task Force on GD of the EHA.
    • Collaborates extensively with international bodies and foundations.

  • Awards and Recognition:

    • Received multiple awards for her contributions and those of her research group members at national and international congresses.
    • Recognized for her innovative work in utilizing artificial intelligence and machine learning in medical research.

  • Teaching and Mentorship:

    • Directed numerous continuing education courses for physicians.

Created educational resources and has been involved in life-long learning activities.

📝🔬Publications📝🔬

  • Elstein D, Belmatoug N, Bembi B, Deegan P, Fernandez-Sasso D, Giraldo P,
    Göker-Alpan Ö, Hughes D, Lau H, Lukina E, Revel-Vilk S, Schwartz IVD, Istaiti M, Botha J,
    Gadir N, Schenk J, Zimran A; GOS Study Group. 2024. Twelve Years of the Gaucher
    Outcomes Survey (GOS): Insights, Achievements, and Lessons Learned from a Global
    Patient Registry.J Clin Med.13-12.
  • Wallace EL, Goker-Alpan O, Wilcox WR, Holida M, Bernat J, Longo N, Linhart
    A, Hughes DA, Hopkin RJ, Tøndel C, Langeveld M, Giraldo P, Pisani A, Germain DP, Mehta
    A, Deegan PB, Molnar MJ, Ortiz D, Jovanovic A, Muriello M, Barshop BA, Kimonis V,
    Vujkovac B, Nowak A, Geberhiwot T, Kantola I, Knoll J, Waldek S, Nedd K, Karaa A, BrillAlmon E, Alon S, Chertkoff R, Rocco R, Sakov A, Warnock DG.;. 2024. Head-to-head trial
    of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and
    deteriorating renal function: results from the 2-year randomised phase III BALANCE
    study. J Med Genet.21-61, pp.520-530.
  • Serrano-Gonzalo I, de Frutos LL, Lahoz-Gil C, Delgado-Mateos F, FernándezGalán MÁ, Morales-Conejo M, Calle-Gordo MV, Ibarretxe-Gerediaga D, MadinaveitiaOchoa A, Albarracin-Arraigosa A, Balanzat-Muñoz J, Correcher-Medina P, García-Frade LJ,
    Hernández-Rivas JM, Labbadia F, López-Dupla JM, Lozano-Almela ML, Mora-Casterá E,
    Noya-Pereira MS, Ruíz-Guinaldo MÁ, Del Mar Tormo-Díaz M, Vitoria-Miñana I, ArévaloVargas I, Andrade-Campos M, Giraldo P. Real life data: follow-up assessment on Spanish
    3
    Gaucher disease patients treated with eliglustat. TRAZELGA project.. 2023. Real life data:
    follow-up assessment on Spanish Gaucher disease patients treated with eliglustat.
    TRAZELGA project. Orphanet J Rare Dis.18-1.
  • Stanescu S, Correcher Medina P, Del Castillo FJ, Alonso Luengo O, Arto
    Millan LM, Belanger Quintana A, Camprodon Gomez M, Diez Langhetée L, Garcia Campos
    O, Matas Garcia A, Perez-Moreno J, Rubio Gribble B, Visa-Reñé N, Giraldo-Castellano P,
    O’Callaghan Gordo M. 2023. Clinical Outcomes of Patients with Chronic Neuropathic
    Form of Gaucher Disease in the Spanish Real-World Setting: A Retrospective
    Study.Biomedicines.11-10.
  • Linhart A, Dostálová G, Nicholls K, West ML, Tøndel C, Jovanovic A, Giraldo P,
    Vujkovac B, Geberhiwot T, Brill-Almon E, Alon S, Chertkoff R, Rocco R, Hughes. 2023.
    Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were
    previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study.
    Orphanet J Rare Dis. 18-1, pp.332.
  • Louw VJ, Fraser I, Giraldo P 2023. Management goals of type 1 Gaucher
    disease in South Africa: An expert Delphi consensus document on good clinical
    practice.PLoS One. 18-8.
  • Esther Valero Tena; Mercedes Roca Espiau; Jose Verdu Diaz; Jordi Diaz
    Manera; Marcio Andrade Campos; Pilar Giraldo Castellano. 2023. Advantages of digital
    technology in the assessment of bone marrow involvement in Gaucher’s disease. Front Med
    (Lausanne).

Rozita Nasiri – Biological Networks – Women Researcher Award

Posted on by ScienceFatherLeave a Comment on Rozita Nasiri – Biological Networks – Women Researcher Award

Dr. Rozita Nasiri distinguished academic and researcher in the field Biological Networks.  She possesses extensive expertise across a wide array of disciplines within biotechnology and biomedical research. Her skills encompass conducting in vitro studies, where she is adept at working with both normal and cancer cells in tissue culture laboratories, proficiently executing various in vitro tests. Additionally, she holds substantial experience in in vivo studies, including working with animal models such as mice and rats to establish conditions like cancer, diabetes, Alzheimer’s, inflammatory bowel disease (IBD), and lead contamination, among others. Her proficiency extends to pharmacology and toxicology, as well as treatment studies.🧬🔗

Furthermore, she is highly skilled in molecular analysis techniques, including PCR, RT-PCR, SDS page, gel electrophoresis, gel extraction, plasmid extraction, dialysis, and genomic and proteomic extraction and isolation. She is also capable of gene and protein sequencing and determining DNA and protein concentrations. Her expertise extends to conducting hematology, immunology, and pathology tests, including biocompatibility studies.🧬

 

🌐 Professional Profiles

Educations📚📚📚

She completed her Bachelor of Science in Microbiology and Biology (Cell and Molecular Biology) from Islamic Azad University (I.R.IRAN) from 2002 to 2006. Following that, she pursued her Master of Science in Biotechnology at UTM (Universiti Technologi Malaysia) from 2009 to 2011, where her research focused on molecular identification of biodegradation related genes from dye-degrading microbes. Subsequently, she earned her PhD in Bioprocess Engineering from the Faculty of Chemical and Energy Engineering, Department of Bioprocess Engineering, spanning from 2012 to 2017. Her doctoral thesis, titled “Synthesis and Characterization of SPIONs-Bromelain-Folic acid on Folic Acid Receptor Positive Cancer Model,” demonstrated her expertise in the synthesis and characterization of nanomaterials for targeted cancer therapy. Throughout her academic journey, she has consistently excelled, maintaining a CGPA of 4 out of 4 for her PhD and 3.62 out of 4 for her Master’s degree.

She has received several notable awards and recognitions for her outstanding contributions to the field of biotechnology and bioprocess engineering. In 2013, she was honored with the Best Paper Award at IGCESH for her research on identifying novel bacterial species capable of degrading Dalapon using 16S rRNA genomic analysis. Additionally, she received the Best New Idea Award from Isfahan University of Medical Sciences, showcasing her innovative thinking and problem-solving skills. Furthermore, her academic excellence was acknowledged through the receipt of an International Doctoral Fellowship from the School of Graduate Studies at UTM, underscoring her dedication to advancing knowledge in her field through research and scholarly endeavors.

Books📚📚📚

1. 2019 “Genetic, Molecular Identification and Bioinformatics Analysis of Carcinogenic Azo Dyes’
Biodegradation related Genes from Citrobacter freundii A1, Enterococcus casseliflavus C1, Enterobacter
cloacae L17 and Candida tropicalis RETL-Cr1 Microorganisms,” Ariyadanesh Press, Iran.
2. 2019 “Synthesis, Characterization and Cancer Therapy Application of Novel Targeted SPIONsBromelainFolic acid Nano-Medicine on FAR+ Cancer Model”, Ariyadanesh Press, Iran.

WORK EXPERIENCE 🧬🔗

She has accumulated a diverse range of professional experiences and roles throughout her career. Initially, she worked as a Medical Laboratory Assistant at Tabatabaei Medical Diagnostic Laboratory and later at Dr. Ghaziasgar Medical Laboratory from 2006 to 2008, where she performed various laboratory tests. Transitioning into academia, she assumed the position of a University Lecturer and Laboratory Instructor at Islamic Azad University, Khorasgan Branch, starting in 2019. In this role, she teaches cell culture techniques, animal handling, and molecular laboratory skills. Simultaneously, she serves as a University Lecturer in English Literature, delivering English courses to undergraduate, master, and PhD students.

Expanding her academic endeavors, she also holds positions as a University Lecturer in Molecular Cell Biology and Biostatistics at the University of Isfahan since 2021, where she imparts knowledge on cell biology, molecular science, and biostatistics. Furthermore, she engages in research activities at the Royan Institute, focusing on the development of inactivated vaccines and antidiarrheal IgY polyclonal antibodies paste products.

Moreover, she plays a significant role as a Co-Supervisor for various Master and PhD projects, supervising research in areas such as nanotechnology, exercise physiology, cancer prevention, and drug development. Additionally, she has conducted research at the Royan Institute and the Dr. Mohammad Shafie Special Center of New Science and Technologies, leading projects focused on vaccine development and R&D in various scientific domains. Her contributions to both academia and research demonstrate her multidisciplinary expertise and commitment to advancing scientific knowledge and innovation.

 

 

 

 

 

 

 

 

 

 

Tianzhu Guan- Biological Networks – Young Scientist Award

Posted on by ScienceFatherLeave a Comment on Tianzhu Guan- Biological Networks – Young Scientist Award

Tianzhu Guan- Biological Networks

Dr. Tianzhu Guan distinguished academic and researcher in the field Biological Network.  Tianzhu Guan a recipient of the 2020 Excellent PhD in the “Green and Golden Phoenix Plan” in Yangzhou City, specializes in the development of nutritional foods with dual applications in medicine and nutrition. His expertise lies at the intersection of cutting-edge scientific disciplines, where he seamlessly integrates Network Science and Graph Analytics into his research. Driven by a passion for advancing food safety, he has a keen focus on the recognition and detection of food hazard factors.

In his groundbreaking work , Tianzhu Guan employs a multifaceted approach, combining molecular techniques such as Molecular Docking, Molecular Dynamic Simulation, and Quantum Chemical Calculation. These methodologies enable him to delve into the intricate molecular interactions within food components, paving the way for innovative solutions in the development of nutritionally enriched foods.

Beyond his computational prowess, He is well-versed in experimental techniques, including Molecular Biology, Western-Blot, and SDS-Page. This dual proficiency empowers him to bridge the gap between theoretical predictions and practical applications, ensuring a comprehensive understanding of the complex relationships between food and medicine.

He is a visionary researcher who not only excels in the theoretical realms of his field but also possesses the practical skills necessary for translating his findings into tangible advancements. His holistic approach to scientific inquiry positions him as a trailblazer in the realm of nutrition and food safety.

Education

He, having pursued a dedicated academic journey, holds a comprehensive educational background in Food Science and Engineering. His academic pursuits commenced with a Bachelor’s degree in Grain Engineering from Jilin Agricultural University, spanning from September 2010 to July 2014. Building upon this foundation, he advanced to earn a Master’s degree in Food Science and Engineering at Jilin University, completing the program from September 2014 to July 2016. His scholarly pursuits culminated in a PhD in Food Science and Engineering from Jilin University, where he engaged in advanced research and academic exploration from September 2016 to October 2019. This extensive and progressively specialized education equips him with a solid foundation and expertise in the intricacies of food science and engineering.

Professional Profiles:

Research Awards

He has garnered significant recognition for his impactful contributions to the field, exemplified by the prestigious Jilin Province Science and Technology Awards. In 2022, he received the second prize in the Natural Science category for his outstanding work on the Mechanism Study of Small Molecule Disruptors in Regulating Estrogen Receptors, demonstrating a keen understanding of the intricate molecular processes involved. Prior to this achievement, in 2020, he secured another second prize in the Natural Science category for his research titled Evaluation of endocrine disrupting effects and residual detection of typical persistent organic pollutants based on receptor recognition. His consistent success in earning accolades underscores his expertise and dedication to advancing scientific knowledge in the domain of endocrine disruption and receptor recognition, further solidifying his position as a distinguished contributor to the field of science and technology.

Funding

⚫ Natural Science Fund for Colleges and Universities in Jiangsu Province of China
(Grant No. 20KJB550002)
⚫ National Youth Talent Sup- port Program of the China Association for Science
and Technology (Grant No. 20220615ZZ07110388)
⚫ Natural Science Foundation of Jiangsu Province, China (Grant No.
BK20200954)
⚫ Laboratory of Xinjiang Native Medicinal and Edible Plant Resources Chemistry,
Kashi University (Grant No. KSUZDSYS202305) Skills

Publication

 

Ahlam H. Mahmoud – Biochemistry – Best Researcher Award

Posted on by ScienceFatherLeave a Comment on Ahlam H. Mahmoud – Biochemistry – Best Researcher Award

Ahlam H. Mahmoud – Biochemistry

Prof Dr. Ahlam H. Mahmoud distinguished academic and researcher in the field Biochemistry. Ahlam Hosny Mahmoud has a rich and extensive employment history in the field of biochemistry and therapeutic chemistry. Beginning in 1987, he served as a research assistant in the Therapeutic Chemistry Department within the Pharmaceutical and Drug Industries Research Division at the National Research Centre in Dokki, Giza, Egypt.

Eduvation

Ahlam has dedicated his career to advancing research in the pharmaceutical and drug industries, contributing significantly to the scientific community. Currently, he holds the esteemed position of Professor of Biochemistry within the same department at the National Research Centre in Dokki, Giza, Egypt. As a professor, he continues to make substantial contributions to the field, shaping the future of biochemistry and therapeutic chemistry through his research and academic endeavors.
Professional Profiles:

EXPERIENCE

In his pursuit of advancing pharmaceutical research, Ahlam Hosny Mahmoud has engaged in a variety of in vivo experiments involving experimental animals. These experiments are designed with the overarching goal of developing new drugs or identifying new drug indications. One facet of his research involves conducting in vivo experiments on gastric ulcer and inflammatory diseases of soft tissue. In these studies, he meticulously induces diseases in experimental animals and evaluates the efficacy of treatments, with a specific focus on assessing the degree of inflammation using a planimeter.

Furthermore, Ahlam is actively involved in in vivo treatments targeting breast cancer. His efforts contribute to the ongoing exploration of novel approaches for combating this prevalent and challenging disease. Additionally, he undertakes experiments aimed at measuring the toxicity of different compounds, providing crucial insights into the safety profile of potential therapeutic agents. Beyond that, Ahlam investigates the distribution and concentration of trace elements in various organs, shedding light on their potential roles in physiological processes and offering valuable information for drug development. Through these diverse in vivo experiments, he remains dedicated to advancing the frontiers of pharmaceutical and therapeutic research.

Project collaboration:

Principal investigator: The potential therapeutic effect of aqueous methanol extract of Bombex ceiba flower against breast cancer in female rats.

**Member: Using modern generations of formulations to prepare safe pesticides from natural materials for pest management in clean agriculture

Publication
  • Development of a New Benzofuran–Pyrazole–Pyridine-Based Molecule for the Management of Osteoarthritis
    Abd El-Karim, S.S., Mahmoud, A.H., Al-Mokaddem, A.K., …Zen, A.A., Anwar, M.M.
    MoleculesThis link is disabled., 2023, 28(19), 6814
  • Calcium voltage-gated channel subunit alpha 1 C and glial fibrillary acidic protein signaling pathways as a selective biomarker in predicting the efficacy of liposomal loaded co-enzyme Q in the autistic rat model
    Elhefnawei, D.M., Mahmoud, A.H., Kadry, M.O., …Badawy, M.A., EL-Desouky, M.A.
    Toxicology ReportsThis link is disabled., 2023, 10, pp. 17–26
  • Antiproliferative activity of bombax ceiba flower extract against mammary gland carcinoma in rats
    Mahmoud, A.H., Metwally, N.S., Youness, E.R., …Elmalt, H.A., Al-Mokaddem, A.K.
    Systematic Reviews in Pharmacy, 2020, 11(11), pp. 1406–1415
  • Synthesis and evaluation of new coumarin derivatives as antioxidant, antimicrobial, and anti-inflammatory agents
    Alshibl, H.M., Al-Abdullah, E.S., Haiba, M.E., …Bari, A., Villinger, A.
    MoleculesThis link is disabled., 2020, 25(14), 3251
  • Phytoconstituents and hepatoprotective effect of Suaeda monoica Forssk and Suaeda pruinosa Lange
    Elsharabasy, F.S., Metwally, N.S., Mahmoud, A.H., …Farrag, A.H., Arafa, S.
    Biomedical and Pharmacology JournalThis link is disabled., 2019, 12(1), pp. 117–129
  • Secondary metabolites and biological activities of allium porrum l. In attacking ehrlich ascites carcinoma in mice
    Mahmoud, A.H., Foda, D.S., Ibrahim, N.E., El-Hagrassi, A.M., Yousef, O.M.H.
    Egyptian Journal of ChemistryThis link is disabled., 2019, 62, pp. 211–227
  • A comparative study of the anticancer activity and PARP-1 inhibiting effect of benzofuran-pyrazole scaffold and its nano-sized particles in human breast cancer cells
    Anwar, M.M., El-Karim, S.S.A., Mahmoud, A.H., Amr, A.E.-G.E., Al-Omar, M.A.
    MoleculesThis link is disabled., 2019, 24(13), 2413
  • Bombax ceiba flowers extract ameliorates hepatosteatosis induced by ethanol and relatively moderate fat diet in rats
    Arafa, A.F., Foda, D.S., Mahmoud, A.H., Metwally, N.S., Farrag, A.R.H.
    Toxicology ReportsThis link is disabled., 2019, 6, pp. 401–408